⭐️⭐️⭐️⭐️⭐️ "A total no brainer"

⭐️⭐️⭐️⭐️⭐️ "Love this, so easy."

Spots is the easy way to track your skin, mole and cancer changes.

Spots Global Cancer Trial Database for Radiation-induced Toxicity in Prostate Cancer/ Standard-Follow-Up Program Prostate

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Trial Identification

Brief Title: Radiation-induced Toxicity in Prostate Cancer/ Standard-Follow-Up Program Prostate

Official Title: Radiation Induced Toxicity in Prostate Cancer

Study ID: NCT03034187

Conditions

Prostate Cancer

Interventions

Study Description

Brief Summary: The goal is to gain insight in the development and course of the toxicity after a curative treatment of prostate cancer

Detailed Description: All with curative intent treated prostate cancer patients will be enrolled in the SFP (Standard Follow-up Programme). It also includes the post -operative adjuvant treatments and the patients with positive lymph nodes. Patients will complete weekly questionnaires to score the patient -rated toxicity. Biweekly patients are seen by the treating radiation oncologist and / or AIOS in which the physician -rated toxicity is scored. In the follow-up will always patient -rated toxicity and physician -rated toxicity can be determined. Use of an SFP should yield a profit for the practitioner , such as the automatic generation of letters. This should apply to all SFPs . Quality of life and toxicity in patients will be completed on the touch-screen computers at FU visits.

Eligibility

Minimum Age: 18 Years

Eligible Ages: ADULT, OLDER_ADULT

Sex: MALE

Healthy Volunteers: No

Locations

University Medical Center Groningen, Groningen, , Netherlands

Contact Details

Useful links and downloads for this trial

Clinicaltrials.gov

Google Search Results

Logo

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

spots app storespots app store

Join others from around the world: